盐酸替罗非班对急性ST段抬高型心肌梗死患者急诊冠状动脉介入术心肌灌注的影响被引量：15

Effects of tirofiban on myocardial reperfusion after primary percutaneous coronary intervention in patients with ST elevation acute myocardial infarction

原文传递

导出

摘要目的:探讨盐酸替罗非班对急性ST段抬高型心肌梗死(STEMI)患者行急诊冠状动脉介入术(PCI)后心肌组织的再灌注影响。方法:符合STEMI入选标准的患者69例,随机分为治疗组(32例)和对照组(37例)。治疗组术前常规给予低分子肝素、阿司匹林、氯吡格雷、调脂药等治疗,术中加用盐酸替罗非班以输液泵持续泵入;对照组除未加盐酸替罗非班外,其他治疗同治疗组。2组术中都常规应用普通肝素。联合应用TMP(TIMI myocardial perfusion)和sumSTR(sum-ST-segment resolution)方法对心肌组织的灌注进行评价。结果:2种评价方法均显示治疗组急诊PCI后心肌组织的再灌注优于对照组(均P<0.05)。结论:盐酸替罗非班能明显改善STEMI患者急诊PCI后心肌组织的再灌注水平。 Objective：To study the situation of myocardial reperfusion after primary percutaneous coronary intervention（PCI） in patients with ST segment elevation acute myocardial infarction （STEMI） who were treated with tirofiban. Method：There were 69 patients diagnosed STEMI in the study. They were randomly divided into 2 groups： treatment group （n=37） and control group （n=32）. Both of them were given low molecular weight heparin, aspirin, clopidogrel and antilipidemic agents before PCI, Heparin were given during and after PCI, the treatment group was treated with tirfiban during and after the operation, The myocardial reperfusion was assessed by TIMI myocardial perfusion and sum-ST-segment resolution. Result：Both assessing methods showed that the myocardial reperfution of treatment group was better than that of control group （P〈0. 05）. Conclusion：Tirofiban can improve the situation of myocardial reperfusion after PCI in patients with STEMI.

作者黄照河侯玉清贾满盈黄铮

机构地区右江民族医学院附属医院心内科南方医科大学附属南方医院心内科

出处《临床心血管病杂志》 CAS CSCD 北大核心 2007年第2期106-108,共3页 Journal of Clinical Cardiology

关键词心肌梗死冠状动脉介入术心肌再灌注盐酸替罗非班 Myocardial infarction Percutaneous coronary intervention Myocardial reperfusion Tirofiban

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献9

1PIANA R N, PAIK G Y, MOSCUCCI M, et al. Incidence and treatment of "no-reflow" after percutaneous coronary intervention[J]. Circulation, 1994, 89:2514-2518.
2SHAH A, WAGNER G S, GRANGER C B, et al.Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment[J]. J Am Coll Cardiol, 2000, 35:666-672.
3VAN'T H A W, LIEM A, SURYAPRANATA H,et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction:myocardial blush grade.Zwolle myocardial infarction study group[J]. Circulation, 1998,97: 2302- 2306.
4FELDMAN L J, COSTE P, FURBER A, et al. Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction[J]. Circulation, 2003,107: 2684- 2689.
5TANAKA A, KAWARABAYASHI T, NISHIBORI Y, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction [J].Circulation, 2002, 105: 2148- 2152.
6REZKALLA S H, KLONER R A. No-reflow phenomenon [J]. Circulation, 2002, 105:656- 662.
7李芳,余素琴,王琳.替罗非班对急性冠状动脉综合征患者临床症状和心电图的影响[J].临床心血管病杂志,2004,20(8):466-467. 被引量：23
8KUNICHIKA H, BEN-YEHUDA O, LAFITTE S,et al. Effects of glycoprotein Ⅱ b/Ⅲ a inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study[J].J Am Coll Cardiol, 2004,43:276-283.
9魏芳晶,张福春,毛节明,郭丽君,李海燕,牛杰,赵一鸣,吕旌桥,郭静萱,高炜.急性心肌梗死经皮冠状动脉介入治疗后心肌灌注的方法评价[J].中华心血管病杂志,2004,32(10):870-873. 被引量：27

二级参考文献13

1Platelet receptor inhibition in ischemic syndrome management(PRISM) study investigators. A comparison of aspirin plus tirofiban with aspirin plus heprin for unstable angina. N Engl J Med, 1998, 338:1498-1505.
2The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein Ⅱ b/Ⅲ a receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.N Engl J Med,1998,338:1488-1497.
3The RESTORE Investigators. Effects of platelet glycoprotein Ⅱ b/Ⅲ a blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation, 1997,96:1445- 1453.
4Piana RN, Paik GY, Moscucci M,et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation, 1994, 89: 2514-2518.
5Shah A, Wagner GS, Granger CB, et al. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the ''gold standard'' for myocardial reperfusion assessment. J Am C
6Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow.Circulation, 1996, 93:879-888.
7van′t Hof AW, Liem A, Suryapranata H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.Circulation, 199
8Feldman LJ, Coste P, Furber A, et al. Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction.Circulation, 2003, 107: 2684-2689.
9Ito H,Taniyama Y,Iwakura K,et al.Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol, 1999, 33: 654-660.
10Kenner MD, Zajac EJ, Kondos GT, et al. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol, 1995, 76: 861-868.